AbbVie (ABBV) valuation, revenue & earnings

P/E and P/S history, revenue and growth, ROIC vs. cost of capital, segments, earnings and analyst forecasts

At a glance
Market capitalisation$469B
Moat ratingWide moat
ValuationFair
Revenue, and where it comes from$61.2bn in 2025: immunology $30.4bn (50%), neuroscience $10.8bn, oncology $6.7bn, aesthetics $4.9bn

Recent years are exact, taken from company filings; the earliest years are approximate. Forecast figures are Wall Street consensus, not company guidance. Read the full AbbVie moat analysis →